# EUS Evaluation of Perianal and Peri-rectal Fistulizing Crohn's Disease With CERTOLIZUMAB Treatment

> **NCT01582568** · — · TERMINATED · sponsor: **Baylor College of Medicine** · enrollment: 1 (actual)

## Conditions studied

- Crohns Disease

## Interventions

- **DRUG:** Certolizumab

## Key facts

- **NCT ID:** NCT01582568
- **Lead sponsor:** Baylor College of Medicine
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2011-06
- **Primary completion:** 2014-03
- **Final completion:** 2014-03
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Not enough subjects to reach accrual goals.
- **Last updated:** 2016-02-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01582568

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01582568, "EUS Evaluation of Perianal and Peri-rectal Fistulizing Crohn's Disease With CERTOLIZUMAB Treatment". Retrieved via MORVS 2026-10-12 from https://api.morvs.ai/clinical/NCT01582568. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*